Years of self-directed use without labs is the most common gap in this audience, and it is the cheapest one to fix: a baseline panel runs $50 to $200 and turns every future decision into a measurement
Spine 31 , 11431148 (2006)
Because of that uncertainty, the FDA labelling recommends weighing the benefits of breastfeeding alongside the mother's need for Zepbound and any possible effects on the baby
It is not approved for human or animal use , and may not be used in food, drugs, cosmetics, or diagnostic applications
29 Encourage Generic Competition Address Structural Barriers to Access Encourage Generic Competition: The lack of generic options for GLP-1 products keeps prices artificially high and limits access for underserved populations
Br J Haematol 2020;190:e2657 11